CHRW
56
-3
MAT
46
12
KMB
39
2
ORCL
65
-2
VMC
57
4
GE
67
2
ILMN
42
5
NAVI
52
5
AA
48
-12
SE
61
-4
CTSH
56
2
MA
64
7
MPC
44
-3
GS
75
2
SLB
55
2
WEC
53
-2
SWK
64
5
VRSN
53
-4
INTU
56
-4
HCA
44
-2
CHRW
56
-3
MAT
46
12
KMB
39
2
ORCL
65
-2
VMC
57
4
GE
67
2
ILMN
42
5
NAVI
52
5
AA
48
-12
SE
61
-4
CTSH
56
2
MA
64
7
MPC
44
-3
GS
75
2
SLB
55
2
WEC
53
-2
SWK
64
5
VRSN
53
-4
INTU
56
-4
HCA
44
-2
Financhill
Back

Arbutus Biopharma Vs. Target Industry Stock Comparison

Sell
37

ABUS
Arbutus Biopharma

Last Price:
3.51
Seasonality Move:
24.22%
Sell
22

TGT
Target

Last Price:
125.00
Seasonality Move:
4.08%
Sell
37
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.51. The Score for ABUS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

  • The current Target [TGT] share price is $125.01. The Score for TGT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • TGT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.

TGT Stock Price Chart

What is Target's stock price today?

  • The Target share price today is $125.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 34.97 Sell
Chaikin Money Flow: 429896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.59 - 4.01) Sell
Bollinger Bands (100): (3.58 - 4.12) Sell

TGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.11 Sell
Relative Strength Index (14 RSI): 28.67 Sell
Chaikin Money Flow: 9125665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (138.23 - 157.41) Sell
Bollinger Bands (100): (141.76 - 157.14) Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.54 Sell
20-day SMA: 3.74 Sell
50-day SMA: 3.89 Sell
200-day SMA: 3.38 Buy
8-day EMA: 3.55 Sell
20-day EMA: 3.69 Sell
50-day EMA: 3.8 Sell
200-day EMA: 3.43 Buy

TGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.68 Sell
20-day SMA: 147.3 Sell
50-day SMA: 151.17 Sell
200-day SMA: 153.74 Sell
8-day EMA: 137.63 Sell
20-day EMA: 145.05 Sell
50-day EMA: 148.83 Sell
200-day EMA: 149.38 Sell

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Target Earnings Growth & TGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.33 per share, an increase this year of $2.81 per share, and an increase next year of $0.33 per share.

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Target Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):